CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Psych Capital PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Psych Capital PLC
17 Hanover Square
Phone: +44 2038387621p:+44 2038387621 LONDON, W1S 1BN  United Kingdom Ticker: PSYPSY
Business Summary
Psych Capital Plc is a United Kingdom-based pure-play psychedelic company. The principal activity of the Company is to identify and invest in companies conducting clinical research programs to develop psychedelic drug development and therapeutic treatments, and business-to-business media and content marketing for the psychedelic science and healthcare industry. It has data and market intelligence platforms. Its PSYCH is a business-to-business (B2B) media and intelligence platform for the psychedelic science and healthcare industry. Its Shortwave Pharma platform works to address the unmet medical needs of patients suffering from treatment resistant mental health and chronic conditions, with a particular focus on eating disorders. Its portfolio also includes Awakn Life Sciences Corp. (Awakn), which is a clinical biotechnology company researching, developing, and delivering evidence-based psychedelic medicine to treat addiction and other mental health conditions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
10/31/20234/30/2023Yes----

Industries
SIC Code Description
6719 Offices of holding companies, not elsewhere classified
6799 Investors, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Rivki S.Youdkevich 11/7/2023 11/7/2023
Executive Director StephenMurphy 36 6/21/2021 6/21/2021
Company Secretary K.Mildwaters 5/3/2022 5/3/2022
Non-Executive Director RoyKait 47 11/7/2023 11/7/2023

General Information
Number of Employees: 1 (As of 4/30/2023)
Outstanding Shares: 290,033,335 (As of 10/31/2023)
Stock Exchange: AQS


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024